Urology

Our research focuses on improving treatment and diagnostic tools to enable us to provide our patients with the best care possible.

Research Goal

Our research team’s main objective is to improve patient care and outcomes in the Urology department at the Alfred hospital as well as in the wider community.

Meet the team

Director

  • A/Prof Jeremy Grummet
    • Pioneer in transperineal biopsy and focal therapy for localised prostate cancer. Served on European and Australian committees to create guidelines for clinical care of prostate cancer

Personal Assistant

  • Julie Humphries

Urologists

  • Mr Nicholas Campbell
  • Mr Christopher Chang
  • Ms Karen McKertich
  • Mr Paul Davis
  • Mr Justin Chee
  • Mr Dennis King
  • Mr Anthony Dat
  • Mr Gideon Blecher
    • Gideon Blecher is a subspecialist urologist with an interest in men’s health urology, male fertility, gender genital surgery as well as genital reconstruction
  • Mr David Wetherell

Nurse

  • Luke Derriman

Prostate Cancer Nurse

  • Dan Kan

Research Coordinator

  • Ashley Baring

Post-grad students

  • Jeremy Cheng

Alfred Urology Consortium (AUC)

We also have a team of highly motivated doctors and students who meet regularly to support and conduct research at The Alfred. These studies have presented widely throughout Australia and in international conferences. Studies have also been published in peer-reviewed journals.

AUC members 2025

  • Jeremy Grummet
  • Marlon Perera
  • Ashley Baring
  • Antara Karmakar
  • Jeremy Cheng
  • Mohammadmehdi Adhami
  • Cam Powell
  • Hyerin Park
  • Ted Risbey
  • Eugene Wang
  • David C Chen
  • Carol Wei
  • Justin Chee
  • Dennis King
  • Ella Beard
  • Jody Khan
  • Ken Chow
  • Felicity Huang
  • Xiang Ren
  • Samiha Arulshankar
  • Sepehr Miran
  • Mitwa Joshi
  • Saman Salaran
  • David Wetherell
  • Priayanka Savanur
  • Jasman Bedi
  • Kamil Ibrahim
  • Greer Waters
  • Genevieve Cox
  • Shirahn Ballah
  • Anthony Dat

Projects

We collaborate widely on many of our projects, and have strong links with PCOR-ANZ, PCOR-VIC, University College London, MSKCC, ANZUP, Royal Melbourne Hospital and the University of Sydney. We have a number of ongoing projects that aim on improving treatment, quality of life and diagnostic tools.

Current projects

  • Clinical registry of focal irreversible electroporation in men with biopsy confirmed low-intermediate risk prostate cancer (FIREFLY) Registry
  • Australian Bladder Cancer (ABC) Registry

Completed trials (no longer recruiting)

2025 Presentations

  • Davis, P. et al.Comparison of Long-term Patient Outcomes of Nesbit and Yachia Corporoplasties for Peyronie's Disease. IMORU IX 2025
  • Blecher, G. Controversies in andrology: ED, penile implants and fertility surgeries. USANZ 2025
  • Grummet, J. Prostate Cancer Focal Therapy: Techniques, innovations and its role in 2025 and beyond. USANZ 2025 
  • Cheng, J. Prostate Cancer Focal Therapy: Techniques, innovations and its role in 2025 and beyond. USANZ 2025
  • Adhami, M. Diagnostic performance of contrast-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast enhanced magnetic resonance imaging in the evaluation of renal masses. USANZ 2025
  • Park, H. Metastatic renal cell carcinoma - trends in prescribing habits. USANZ 2025
  • Adhami, M. Oncological outcomes post focal low-dose-rate brachytherapy in men with low-intermediate risk prostate cancer- results from liberate registry. USANZ 2025
  • Blecher, G. Testicle preserving surgery for testicular cancer. USANZ 2025
  •  Features and management of lymphomas diagnosed incidentally in prostatic tissue obtained from surgical lower urinary tract symptoms treatment: A systematic review USANZ 2025
  • Cheng, J. Oncological outcomes post focal low-dose-rate brachytherapy in men with low-intermediate risk prostate cancer - results from LIBERATE registry. RACS ASC 2025
  • Risbey, T. et al. Uptake of Active Surveillance in favourable intermediate risk prostate cancer in Victoria: An analysis of the Prostate Cancer Outcomes Registry (PCOR) data set. RACS ASC 2025
  • Park, H. et al. AFL-related renal traumas - a 15 year Australian tertiary trauma centre experience. RACS ASC 2025
  • Blecher, G. Penile implant course. Colopalst UCLH 2025
  • Grummet. J. MRI working group for national guideline update, currently open for public comment. PCFA 2025
  • Blecher, G. T-shunt (how I do it). Coloplast Masterclass 2025
  • Miran, S. et al. A comprehensive look into robotic and laparoscopic partial nephrectomy: Achievement of Trifecta and optimal outcomes in surgical treatment of renal masses by a single surgeon. ANZUP ASM 2025
  • Management of complex Large renal masses (>70mm) by a single surgeon; Robotic and Laparoscopic partial nephrectomy. ANZUP ASM 2025
  • Miran, S. et al. A Comparative Analysis of Robotic vs Laparoscopic Partial Nephrectomy for a Complex Renal Mass (R.E.N.A.L. Score ≥ 10); Single surgeon study. ANZUP ASM 2025
  • Cheng, J et al. Clinical Registry Protocol for FIREFLY: A Clinical Registry of Focal Irreversible Electroporation in Men with Biopsy Confirmed Low-Intermediate Risk Prostate Cancer. ANZUP ASM 2025
  • Grummet, J. Prostate cancer detection - Implementing new guidelines in general practice. Healthed conference 2025
  • Grummet, J. New national PSA testing guidelines. Healthed Conference 2025
  • Davis, P. Boston Scientific Monash Health Prosthetic Workshop. 2025
  • Blecher, G. Innovations in Surgical Treatment of PD Girth Loss Deformity. SMSNA 2025
  • Blecher, G. Latest Techniques in Vaginoplasty/Vulvoplasty. SMSNA 2025
  • Cheng, J. How Accurate is 68Ga PSMA PET/MRI in localizing primary prostate cancers compared to multiparametric MRI, Ga68 PSMA PET/CT and whole-mount histopathology? USANZ 2019
  • Cheng, J. What is the accuracy of 68Ga-PSMA PET/CT in detecting primary prostate cancers compared to multiparametric MRI? USANZ 2019